Independent analysis puts a TFC mazdutide lot at 98.1%, against 94.2% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
August 2024 — Vol. 1, No. 8
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, August 2024What an 18% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What the new Singapore guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Shenzhen: 6 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Canada health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
SURMOUNT-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A shortage listing ends. 14 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Poland pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
South Korea health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
The consolidator trading as Meridian Freight Partners closes after 10 years
A proper account of an operation that existed, and of what closing it cost.
What the new India guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 25% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
VendorInvestigate result on a Tianjin tirzepatide lot lands 0.7 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
France pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Wuxi export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
India declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.